The preliminary characterization of a vasoactive circulating factor(s) in preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 184, Issue 6, 2001, Pages 1196-1203

  Hayman, Richard ^a,b   Warren, Averil ^a   Johnson, Ian ^a   Baker, Philip ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Circulating factor; Endothelium; Myography; Plasma; Resistance arteries

Indexed keywords

BRADYKININ; ENDOTHELIUM DERIVED RELAXING FACTOR; GLYCOPROTEIN; PLASMA PROTEIN; PROTEASOME;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; HUMAN; HUMAN TISSUE; MUSCLE RELAXATION; MYOGRAPHY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DENATURATION; RESISTANCE BLOOD VESSEL; UTERINE ARTERY; UTERUS CONTRACTION;

EID: 0035340098     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2001.113130     Document Type: Article

References (25)

1. Lewis G, Drife JO. Why Mothers Die: Report on Confidential Enquiries into Maternal Deaths in the United Kingdom, 1994-1996. London: Dept. of Health, Welsh Office, Scottish Office Dept. of Health, Dept. of Health and Social Services, Northern Ireland; 1998.
2. Brosens IA. Morphological changes in the utero-placental bed in pregnancy hypertension. Clin Obstet Gynecol 1977;77:573-93.
3. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Pre-eclampsia: An endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-4.
4. Baker PN, Davidge ST, Roberts JM. Plasma from women with pre-eclampsia increases endothelial cell nitric oxide production. Hypertension 1995;26:244-8.
5. Baker PN, Davidge ST, Barankiewicz J, Roberts JM. Plasma of pre-eclamptic women initially stimulates and then inhibits endothelial cell prostacyclin production. Hypertension 1996;27:56-61.
6. Aalkjaer C, Danielsen H, Johannesen P, Pedersen B, Ramussen A, Mulvany MJ. Abnormal vascular function and morphology in preeclampsia: A study of isolated resistance vessels. Clin Sci 1985;69:477-82.
7. Pascoal IF, Lindheimer MD, Nalbantian-Brandt C, Umans JG. Preeclampsia selectively impairs endothelium dependent relaxation and leads to oscillatory activity in small omental arteries. J Clin Invest 1998;101:464-70.
8. McCarthy AL, Woolfson RG, Raju SK, Poston L. Abnormal endothelial cell function of resistance arteries in women with preeclampsia. Am J Obstet Gynecol 1993;168:1323-30.
9. Ashworth JR, Warren AY, Baker PN, Johnson IR. Loss of endothelium-dependent relaxation in myometrial resistance arteries in pre-eclampsia. Br J Obstet Gynaecol 1997;104:1152-8.
10. Hayman R, Sattar N, Warren AY, Greer I, Johnson I, Baker PN. A relationship between myometrial resistance artery behaviour and circulating lipid composition. Am J Obstet Gynecol 1999;180:381-6.
11. Hayman R, Warren AY, Brockelsby J, Johnson IR, Baker PN. Plasma from women with pre-eclampsia induces an in vitro alteration in the endothelium dependent behaviour of myometrial resistance arteries. BJOG 2000;107:108-15.
12. Wilcox MA, Johnson IR, Maynard PV, Smith SJ, Chilvers CE. The individualised birthweight ratio: A more logical outcome measure of pregnancy than birthweight alone. BJOG 1993;100:342-7.
13. Ashworth JR, Warren AY, Baker PN, Johnson IR. A comparison of endothelium-dependent relaxation in omental and myometrial resistance arteries in pregnant and nonpregnant women. Am J Obstet Gynecol 1996;175:1307-12.
14. Mulvany MJ, Halpern W. Mechanical properties of vascular smooth muscle cells in situ. Nature 1976;260:617-9.
15. Harris ELV. Protein purification methods, a practical approach. In: Harris ELV, Angal S, editors. Practical Approach Series. Oxford (UK): IRL Press; 1989.
16. Chen RF. Removal of fatty acids from serum albumin by charcoal treatment. J Biol Chem 1967;242:173-81.
17. Ashworth JR, Baker PNB, Warren AY, Johnson IRJ. Plasma from pre-eclamptic women induces a functional change in myometrial resistance arteries [abstract]. J Soc Gynecol Investig 1997;4:96A.
18. Davidge ST, Signorella AP, Hubel CA, Lykins DL, Roberts JM. Distinct factors in plasma of pre-eclamptic women increase endothelial nitric oxide or prostacyclin. Hypertension 1996;28:758-64.
19. Potter JM, Nestel PJ. The hyperlipidemia of pregnancy of normal and complicated pregnancies. Am J Obstet Gynecol 1979;130:165-70.
20. Meekins JW, McLaughlin PJ, West DC, McFadyen IR, Johnson PM. Endothelial cell activation by tumour necrosis factor-alpha (TNF-alpha) and the development of pre-eclampsia. Clin Exp Immunol 1994;98:110-4.
21. Brockelsby JC, Anthony F, Johnson IRJ, Wheeler T, Baker PN. Increased serum vascular endothelial growth factor concentrations in preeclampsia. Hypertens Pregn 1998;17:283-90.
22. Brockelsby J, Hayman R, Warren A, Johnson I, Baker P. Pre-eclampsia: A role for vascular endothelial growth factor [abstract]. J Soc Gynecol Investig 1998;5:67A.
23. de Groot CJ, Davidge ST, Friedman SA, McLaughlin MK, Roberts JM, Taylor RN. Plasma from pre-eclamptic women increases human endothelial cell prostacyclin production without changes in cellular enzyme activity or mass. Am J Obstet Gynecol 1995;172:976-85.
24. Davidge ST, Baker PN, Roberts JM. Nitric oxide synthase expression is increased in endothelial cells exposed to plasma from women with preeclampsia. Am J Physiol 1995;269:H1106-12.
25. Hayman R, Brockelsby J, Warren A, Ashworth J, Johnson I, Baker P. Evidence for a circulating factor in pre-eclampsia: A role for vascular endothelial growth factor? BJOG 1998;105:39-40.